Funding round
Ultima Genomics Growth
Reported as "Growth Equity"
Ultima Genomics, which works in high-throughput DNA sequencing platform manufacturing in Fremont, raised $600M in a Growth round announced on 1 Jun 2022. 8 firms took part.
$600M
Amount raised
Not disclosed
Post-money valuation
8
Investors
no lead named
Valuation
What this round says about the price
Ultima Genomics did not disclose a valuation in this round. It is Ultima Genomics' first venture round on record, 6 years after it was founded in 2016. No later venture round is on record for Ultima Genomics.
Ultima Genomics' funding rounds
This is the only venture round on record for Ultima Genomics.
- Growth this round 1 Jun 2022 $600M
Investors
Who put money in
8 firms took part; no lead investor was named.
Investors
- General Atlantic backs 134 venture-backed companies new investor
- Andreessen Horowitz backs 722 venture-backed companies new investor
- D1 Capital new investor
- Khosla Ventures backs 396 venture-backed companies new investor
- Lightspeed Venture Partners backs 454 venture-backed companies new investor
- backs 28 venture-backed companies new investor
- backs 51 venture-backed companies new investor
- Founders Fund backs 368 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to scaling operations.
- Scaling operations
Comparable rounds
How it compares
22 Growth rounds in Biotechnology within a year either side disclosed an amount; the median was $58M, and this round was 10 times the median. The closest in time, other companies' Growth rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 21 Jun 2022 | $5.0M | not disclosed | not named |
| Biotechnology | 7 Jun 2022 | undisclosed | not disclosed | not named |
| Biotechnology | 11 May 2022 | $26M | not disclosed | Eli Lilly and Company and Sound Bioventures |
| Biotechnology | 22 Mar 2022 | $175M | not disclosed | Vida Ventures and Leaps by Bayer |
| Biotechnology | 16 Feb 2022 | $100M | not disclosed | not named |
| Biotechnology | 19 Oct 2022 | $55M | not disclosed | Novartis Venture Fund |
| Biotechnology | 3 Oct 2022 | undisclosed | not disclosed | not named |
| Biotechnology | 14 Nov 2022 | $119M | not disclosed | not named |
Sources
Where this comes from
Reported by 5 sources. The deal data marks this round as not yet confirmed by an official announcement. Unconfirmed
Questions
Frequently asked
How much did Ultima Genomics raise in its Growth round?
Ultima Genomics raised $600M in its Growth round, announced in Jun 2022.
Which investors took part in Ultima Genomics' Growth round?
General Atlantic, Andreessen Horowitz, D1 Capital, Khosla Ventures, Lightspeed Venture Partners and aMoon and 2 more.
What was Ultima Genomics' valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Biotechnology?
22 Growth rounds in Biotechnology within a year either side disclosed an amount; the median was $58M, and this round was 10 times the median.